SOURCE: Wall Street News Alert

December 08, 2005 09:52 ET

Wall Street News Alert: Emerging Public Company Achieves Record November Revenue Results! December 8, 2005

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.

WESTON, FL -- (MARKET WIRE) -- December 8, 2005 -- Wall Street News Alert's "stocks to watch" this morning are: MEDirect Latino Inc. (OTC: MLTO), Guidant Corporation (NYSE: GDT), Dendreon Corporation (NASDAQ: DNDN) and Bristol-Myers Squibb Company (NYSE: BMY).

MEDirect Latino Inc. (OTC: MLTO) could be one of the targets of aggressive investors and day traders this morning! Yesterday after the stock markets closed, the company, the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community, issued a press release announcing record results for November, 2005 in gross billings, new patient shipments and call volume.

The news of the record results may get the attention of investors, as the company reported some very strong numbers! MEDirect Latino reports gross billings of $540,114 during the month, a 29% increase over October billings of $418,406. The Company maintained gross product profit margins of 77% during the period. Total new patient shipments for November numbered 2,030, an increase of 30% over October new shipments of 1561, and ended the month with an additional 1,908 patients approved and pending shipment for regulatory processing. MEDirect Latino expects to monetize its approved and pending patient orders in December, which is typical to the industry model. The Company's closing ratio during November remained unchanged at 82% of the total qualified response rate from its national and regional media campaigns.

Continue to watch this company! Mr. Raymond Talarico, Co-Chairman and CEO, "The Company continues to meet or exceed our projections each month as we focus on providing critical services to the underserved Hispanic Medicare eligible diabetic customer. Management designed each department's infrastructure; customer care, sales, billing, processing and fulfillment, to be scalable and responsive to our customer acquisition objectives which provides management great flexibility in the placement of advertising, both nationally and regionally. The Company increased its sales and processing and fulfillment staffing to 39 employees by the end of November from 24 in October, with the additional employees hired to meet increased demand. We have been able to integrate these new staff members seamlessly, without a drop in our efficiency as indicated by maintaining our closing ratio during the month. As a first mover to market, MEDirect utilizes this scalability to provide both high quality health care products to our customers, and at the same time, set industry standards for the quality of care for our elderly Hispanic community. This is a responsibility the Company does not take lightly, and has proven to be important as new customers migrate from traditional Anglo providers to MEDirect, because we understand our customers needs and are sensitive to the cultural considerations."

Investors should continue to monitor the progress of MEDirect Latino! The current Hispanic market for MEDirect's products is conservatively estimated at approximately $748MM in the continental United States. The size of the opportunity is understated by such figures as an estimated 1.2 million of the over 4.1 million Hispanics in the United States over 65 eligible to receive Medicare benefits are currently collecting these benefits with an estimate that over 1.4 million of those Medicare-eligible Hispanics have diabetes (implying a potential continental U.S. market for MEDirect products of approximately $1 billion).

Prior to the latest press release, the stock closed yesterday at $5.25 a share.

For an in-depth profile of MEDirect Latino, visit

In case you are not familiar with the company: MEDirect Latino is a rapidly growing, uniquely positioned provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community in the United States and Puerto Rico. MEDirect is the only company positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. The Company's current focus is the distribution of products for the treatment of Type II diabetes specifically because of its disproportionate impact and increasing diagnosis rate within the US Hispanic population, noting an incidence of 120% higher than among non-Hispanic whites. Type II diabetes was also targeted because of its unique status within the Medicare reimbursement regime and because of its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These other conditions represent considerable future market potential that will allow MEDirect to efficiently scale its model by leveraging its existing client base and infrastructure.

Stocks showing interesting activity yesterday at the close of the regular trading day were: Guidant Corporation (NYSE: GDT) down 0.5% on 8.3 million shares traded, Dendreon Corporation (NASDAQ: DNDN) down 3.1% on 8 million shares traded and Bristol-Myers Squibb Company (NYSE: BMY) down 0.4% on 7.7 million shares traded.


"Stocks fell moderately yesterday with the Dow ending down 45.95 at 10,811 and the Nasdaq closing down 8.75 at 2,252. It seems investors are cautious and have found little reason to extend year-end buying spree," stated Sonja Rudd in Wall Street News Alert's daily commentary continued at:

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 50 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at and select the "join now" button.

*** Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street! If you receive any such fax, please do not contact us at You may wish to inquire about the fax, with the CEO of the company that the fax is written about ***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. WSCF has been compensated Fifty-Four Thousand Dollars for past coverage and Fifteen Thousand Dollars for current coverage of MEDirect Latino Inc. (OTC: MLTO), by a third party (TBeck Capital Inc.), who is non-affiliated and may hold a significant position in the stock, for services provided including dissemination of company information in this release. WSCF holds no shares of the stock. WSCF may receive shares for extension of its services. Any shares will be disclosed at such time that WSCF is aware of a client's desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.

Contact Information